Kyle Jones, PMHNP: The Future of Telehealth for ADHD

Video

Telehealth likely will have a major place in psychiatric care in the future.

The COVID-19 pandemic ushered in a new era of telehealth. However, no medical specialty is better suited for this future than psychiatry.

Psychiatrists for the last 3-plus years have really utilized telehealth principles to maintain care for patients with diseases like attention deficit/hyperactivity disorder (ADHD) and other psychiatric conditions.

But as the pandemic concludes, there will be a renewed push for more of a hybrid care program, where patients do visit offices, while also utilizing telehealth modalities.

In an interview with HCPLive®, Kyle Jones, PMHNP, Done ADHD, explained how effective telehealth has been moving forward and what is important in the future, not only to help patients, but also to help alleviate burnout within medical professionals.

“Psychiatry certainly lends itself well to telehealth care,” Jones said. “Patients were used to seeing us in person as well. Telehealth really exploded with the start of the pandemic.

However, Jones said there will be a push to in person meetings that the patients will ultimately enjoy.

“As we go back to it, I feel like patients are just going to feel like its normal,” he said.

Telehealth also has a place to stay in many states and will be utilized more in larger states like Texas, where patients have doctors that could potentially be several hours away.

Related Videos
Manish Jha, MD: Treatment Options for Treatment-Resistant Depression
Katharine Phillips, MD: Differences Between OCD, Body Dysmorphic Disorder
Brian Barnett, MD: Psychedelics Fitting into the SUDs Treatment Paradigm
Lenard A. Adler, MD: “Symptoms of ADHD Need to Go Back to Childhood”
3 Barriers to Improving Clozapine Use in Treatment-Resistant Schizophrenia
Evaluating MM120 for GAD with Daniel Karlin, MD, and Reid Robinson, MD, MBA
Daniel Karlin, MD: Prevalence of Undiagnosed Generalized Anxiety Disorder
The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert
Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future
© 2024 MJH Life Sciences

All rights reserved.